Liver transplantation is the sole curative option for HCC, but new therapies prompt reconsideration of transplant timing and ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

Hepatocellular carcinoma (HCC ... Recent advancements in liver imaging, particularly the use of hepatocyte-specific contrast ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma ... It can mask residual vascularity on CT imaging and its use is not recommended.

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.

Long-term use of statins may delay or deflect the development of hepatocellular carcinoma in adults with chronic liver disease, as well as in the general population, emerging research, including ...